Macupatide Clinical Trials

2 actively recruiting trials across 2 locations

▲ +1 trial since June 2026

Also known as: LY3532226

Pipeline

Phase 2: 2

Top Sponsors

Eli Lilly and Company2

Indications

Diabetes2
Overweight2
Obesity2
Weight Loss1
Diabetes Mellitus, Type 21

Chandler, Arizona1 trial

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

The Institute for Liver Health II dba Arizona Clinical Trials - Mesa

Phase 2

Gilbert, Arizona1 trial

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.